Matches in Wikidata for { <http://www.wikidata.org/entity/Q65383490> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q65383490 description "clinical trial" @default.
- Q65383490 description "ensayu clínicu" @default.
- Q65383490 description "klinisch onderzoek" @default.
- Q65383490 description "клінічне випробування" @default.
- Q65383490 name "Pivotal Study in Advanced Parkinsons Disease Patients" @default.
- Q65383490 name "Pivotal Study in Advanced Parkinsons Disease Patients" @default.
- Q65383490 type Item @default.
- Q65383490 label "Pivotal Study in Advanced Parkinsons Disease Patients" @default.
- Q65383490 label "Pivotal Study in Advanced Parkinsons Disease Patients" @default.
- Q65383490 prefLabel "Pivotal Study in Advanced Parkinsons Disease Patients" @default.
- Q65383490 prefLabel "Pivotal Study in Advanced Parkinsons Disease Patients" @default.
- Q65383490 P1050 Q65383490-65F934B9-F1C3-47C5-AA7B-962EEA7956A9 @default.
- Q65383490 P1132 Q65383490-0AF4DF5F-83A2-43CB-A8C3-3ED02FBB0F3D @default.
- Q65383490 P1476 Q65383490-A6410BD9-551B-428C-A671-755D73482D2A @default.
- Q65383490 P17 Q65383490-07C73143-777C-4743-A587-C7215DEA09B8 @default.
- Q65383490 P17 Q65383490-245D352A-3ACA-4703-AD9F-A2AA88362D6E @default.
- Q65383490 P17 Q65383490-3C4B3935-4465-4779-9E74-FB178A88DEA3 @default.
- Q65383490 P17 Q65383490-48123220-847A-43CA-86DA-17300C87FAD6 @default.
- Q65383490 P17 Q65383490-72BC3D61-83F9-4A59-A117-822E8C92B9A0 @default.
- Q65383490 P17 Q65383490-7B7BE0E0-3183-4DC9-BEE8-FD812DB057CA @default.
- Q65383490 P17 Q65383490-813FC2CD-BA8D-46B6-AE16-1430603AB0C0 @default.
- Q65383490 P17 Q65383490-A3943724-A2F9-4EE2-95E1-72E59D64AB8A @default.
- Q65383490 P17 Q65383490-B484B8C9-D81B-4DB5-8219-DE2200F1F999 @default.
- Q65383490 P17 Q65383490-C323231C-082B-4436-BF28-CE8F331A3FA0 @default.
- Q65383490 P17 Q65383490-E5043F59-C951-49E3-B653-29D7B7432FA0 @default.
- Q65383490 P17 Q65383490-ECB5E457-38B1-4307-A6A8-C212BFAF46AE @default.
- Q65383490 P2899 Q65383490-932DF127-5B0C-4F88-82DA-C72B0E29BF4E @default.
- Q65383490 P3098 Q65383490-67137FB2-A7AE-41FD-8779-F5ED784DB6B1 @default.
- Q65383490 P31 Q65383490-14BA9F7C-A4FF-4345-8A55-8DFCA2DB93A1 @default.
- Q65383490 P4844 Q65383490-93291D37-90F5-4FBB-BE9E-9B696C0D85E8 @default.
- Q65383490 P580 Q65383490-82108E1D-1543-4412-A8F5-EB6E3EB55416 @default.
- Q65383490 P582 Q65383490-21C560AC-E3A0-4C01-86CD-12F13A35AF1D @default.
- Q65383490 P6099 Q65383490-05A5E332-EA82-4DBE-8A3B-D778C6F9666F @default.
- Q65383490 P8363 Q65383490-D9C7178E-1900-4FDF-97C6-42C4F9497971 @default.
- Q65383490 P1050 Q11085 @default.
- Q65383490 P1132 "+517" @default.
- Q65383490 P1476 "A Double-blind, Double-dummy, Placebo-controlled, Randomized, Three Parallel Groups Study Comparing the Efficacy, Safety and Tolerability of Pramipexole Extended Release (ER) Versus Placebo and Versus Pramipexole Immediate Release (IR) Administered Orally Over a 26-week Maintenance Phase in L-Dopa+ Treated Patients With Advanced Parkinsons Disease (PD)." @default.
- Q65383490 P17 Q145 @default.
- Q65383490 P17 Q212 @default.
- Q65383490 P17 Q213 @default.
- Q65383490 P17 Q214 @default.
- Q65383490 P17 Q28 @default.
- Q65383490 P17 Q29 @default.
- Q65383490 P17 Q34 @default.
- Q65383490 P17 Q36 @default.
- Q65383490 P17 Q38 @default.
- Q65383490 P17 Q40 @default.
- Q65383490 P17 Q668 @default.
- Q65383490 P17 Q928 @default.
- Q65383490 P2899 "+32" @default.
- Q65383490 P3098 "NCT00466167" @default.
- Q65383490 P31 Q30612 @default.
- Q65383490 P4844 Q421304 @default.
- Q65383490 P580 "2007-04-01T00:00:00Z" @default.
- Q65383490 P582 "2008-11-01T00:00:00Z" @default.
- Q65383490 P6099 Q42824827 @default.
- Q65383490 P8363 Q78089383 @default.